Clinical Trial Update: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer [Phase 2]

View source ↗

Summary

This Phase II clinical trial update evaluates a multimodal therapy consisting of intensity-modulated radiation therapy with cisplatin and bevacizumab, followed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Adenosquamous Carcinoma
• Endometrial Cancer
• Endometrial Clear Cell Adenocarcinoma
• Endometrial Serous Adenocarcinoma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Carboplatin (Paraplatin) (carboplatin)
• Cisplatin (Platinol) (cisplatin)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-24